ArticleOncoTargets and therapy2017
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α.
Xue Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncoTargets and therapy2017
Xue Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.